Recent research published in JMIR mHealth and uHealth suggests that a wearable device delivering gentle vibrations to the body can help people sleep longer. The findings provide evidence that this non-invasive technology tends to significantly increase total sleep time, especially for individuals who typically struggle to get a full night of rest. This approach offers a promising, medication-free option for addressing chronic sleep shortages and improving overall health.
A significant portion of the global population fails to get enough sleep each night. In the United States, roughly 70 million adults sleep six hours or less on a regular basis. Medical professionals refer to this condition as chronic short sleep. The Centers for Disease Control and Prevention recommends that adults obtain at least seven hours of sleep per night to maintain optimal physical and mental well-being.
Falling short of this recommendation is associated with a variety of negative health outcomes. Chronic lack of sleep tends to increase the risk of cardiovascular disease, diabetes, obesity, and mood disturbances. It can also impair cognitive functions like memory consolidation and daily concentration. Because of these substantial health risks, many individuals actively seek out methods to extend their nightly rest.
Historically, people have turned to behavioral changes, cognitive behavioral therapy, or medications to improve their rest. Prescription sleep medications can be highly effective at inducing sleep, but they often come with unwanted side effects like dizziness, next-day drowsiness, or even bizarre nighttime behaviors. Over-the-counter supplements like melatonin offer a milder alternative, but they tend to yield only modest increases in actual sleep time. Scientists are actively exploring alternative interventions that require minimal user effort and completely avoid pharmacological side effects.
One emerging technology is transcutaneous vibratory stimulation, which involves applying rhythmic, tactile vibrations directly to the skin. The concept is based on the idea that gentle, low-frequency sound waves can mimic the calming sensation of soothing human touch. This kind of tactile stimulation is thought to influence the autonomic nervous system, which controls involuntary bodily functions like heart rate and digestion. By shifting the body away from a state of stress and into a state of relaxation, this technology might help the nervous system prepare for sleep.
The authors of the new study wanted to examine how this specific type of vibratory stimulation impacts sleep patterns in a real-world setting. A previous trial had shown that the technology improved sleep in patients with a specific autoimmune condition. The researchers aimed to build on that earlier work by quantifying the device’s impact on a much larger, general population over an extended period. They specifically focused on whether the duration of the device’s use correlated with measurable extensions in total sleep time.
To conduct the study, the researchers analyzed retrospective data from a community of individuals who used both the Apollo wearable device and the Oura Ring. The Apollo device is a consumer wellness product worn on the wrist or ankle that delivers targeted vibratory stimulation through the skin. The Oura Ring is a separate biometric tracking device worn on the finger that uses movement, heart rate, and temperature sensors to monitor sleep phases. The study relied on data collected naturally as users interacted with these commercial devices in their everyday lives between January 2019 and May 2022.
The final sample included 935 users, which provided an extensive dataset of 474,852 nights of observation. Most of the participants were between the ages of 36 and 64, and about 52 percent of the sample identified as male. To establish a baseline for each user, the researchers required participants to have at least seven nights of recorded sleep data before they ever used the vibratory wearable at night. The research team then grouped the participants based on their baseline sleep habits, creating specific categories for those who naturally slept less than six hours, six to seven hours, seven to eight hours, and eight to nine hours.
The researchers measured the nightly use of the Apollo device in minutes, categorizing the usage into distinct levels ranging from zero minutes to over 240 minutes. They then used advanced statistical frameworks, including linear mixed-effects models, to analyze how different amounts of nighttime vibration influenced total sleep time. This type of statistical model allows researchers to control for individual differences, ensuring that a user with hundreds of logged nights does not incorrectly skew the data compared to a user with fewer nights. The primary outcome measured was the change in total sleep time, recorded in minutes by the smart ring.
The analysis revealed that nighttime use of the vibratory wearable was significantly associated with an increase in total sleep time. This effect was dose-dependent, meaning that longer use of the device generally corresponded to greater extensions in sleep. For the group of short sleepers who normally received six hours of rest or less, using the device for more than 240 minutes per night resulted in an average sleep extension of about 46 minutes. The median total sleep time for these individuals increased from 350 minutes to 381 minutes on nights they used the maximum level of stimulation.
Participants who already had longer baseline sleep durations also experienced benefits, though the absolute increases were slightly smaller. For instance, people who typically slept between six and seven hours gained an average of 35 additional minutes of sleep when using the device for over 240 minutes. Those sleeping seven to eight hours gained an estimated 13 additional minutes. This indicates that the vibratory stimulation provides evidence of sleep enhancement across several different baseline habits.
The researchers also looked at how the extra sleep was distributed across different sleep phases, such as light sleep, deep sleep, and rapid eye movement sleep. Rapid eye movement, or REM, is a stage of sleep associated with dreaming and emotional processing. For the short sleepers, the data showed an approximate six percent increase in the proportion of time spent in the REM phase. This increase in REM sleep came at the expense of light sleep, suggesting the additional rest maintained a healthy overall sleep architecture.
In addition to extending total sleep time, the vibratory stimulation was linked to a lower probability of experiencing a severely shortened night of rest. The authors calculated the odds of a participant sleeping six hours or less on any given night. For short sleepers, using the device for more than 240 minutes was associated with a 77 percent reduction in the odds of having a short sleep night. Even moderate use of the device, between 181 and 240 minutes, was associated with a 49 percent reduction in these odds.
A few limitations must be considered when interpreting these findings. The study used an observational design based on retrospective data, which means it can identify correlations but cannot definitively prove that the device directly caused the sleep improvements. Because the researchers analyzed existing commercial data, they could not control for outside factors that might influence sleep, such as caffeine intake, alcohol consumption, or daily medication use. The lack of direct interaction with participants also means the team could not verify if the devices were always used exactly as the manufacturer intended.
The reliance on biometric wearable devices presents another constraint for the research team. Although the smart ring provides validated, objective measurements of sleep phases, the study did not include subjective assessments from the users. Subjective measures, like structured sleep quality questionnaires, help scientists understand how rested a person actually feels the next day. Relying purely on device data means the psychological perception of sleep quality remains unknown for this specific sample.
Future research will need to address these gaps by conducting randomized controlled trials in clinical settings. Such trials would involve specific, supervised protocols to establish a direct causal relationship between vibratory stimulation and sleep extension. Scientists also suggest examining how this technology affects diverse populations, including people diagnosed with clinical sleep disorders or distinct neurological conditions. Integrating standardized sleep quality surveys into future studies would help provide a complete picture of how transcutaneous vibratory stimulation impacts human health.
The study, “Association Between Duration of Transcutaneous Vibratory Stimulation Delivered by the Apollo Neuro Device and Extension of Total Sleep Time,” was authored by Mahender Mandala, Shilpa Krishnan, Nathanial Weathington, Michael Breus, and David Rabin.
Leave a comment
You must be logged in to post a comment.